www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

US EUROPE AFRICA ASIA 中文
Business / Companies

Guilin at forefront in battle against malaria

By Wang Hongyi (China Daily) Updated: 2015-11-09 09:47

Since 2000, global mortality rates among malaria patients have dropped by 47 percent. In Africa, the rate has come down by 54 percent for adults and 58 percent for children.

GPSC has played an important role, along with major global pharmaceutical companies such as Novartis in Switzerland and Sanofi-Aventis in France, in fighting malaria.

The Chinese company was at the forefront in developing the innovative artesunate vaccine, Artsun, the first of its kind, to replace quinine injections. The WHO has compared it to the "gold standard" in the battle against malaria.

Artsun is now registered in more than 30 countries and regions and has a 90 percent market share in treating servere malaria.

During the past three years, GPSC has supplied 23.8 million units of the vaccine globally, saving more than 3.4 million people from the scourge of malaria.

"This is an innovative drug that was developed in China," Guo Guangchang, chairman of Fosun Group, said.

During the past decade, 13 anti-malaria drugs developed by GPSC have been approved by the WHO, including three which are injected and 10 in oral tablets.

The company's products account for 80 percent of China's anti-malaria drug exports.

In the first three quarters of this year, Fosun Pharmaceutical, which includes GPSC, reported revenue of 9 billion yuan ($1.41 billion), a rise of 4.76 percent compared to the same period in 2014.

Further financial details have yet to be released. The company's products include metabolism and digestive system drugs, and vaccines, as well as GPSC's brands.

"At present, Guilin Pharma is building a new manufacturing site which will comply with (international) standards," GPSC said.

"In future, we will have a production capacity of over 15 billion tablets/capsules per year to meet the needs of both domestic and global markets." the company added.

Fosun Pharmaceutical also plans to expand its research and development program by working alongside institutions and other organizations.

"There should be more cooperation with research institutes and organizations," Chen Qiyu, chairman of Fosun Pharmaceutical, said.

"This would help create a much larger platform, allowing us to do a better job globally."

Previous Page 1 2 Next Page

Hot Topics

Editor's Picks
...
主站蜘蛛池模板: 久久精品免视看国产明星 | 一级免费看片 | 亚洲 欧美 日韩 在线 中文字幕 | 亚洲天堂免费观看 | 91精品视品在线播放 | 中国精品视频一区二区三区 | 精品国产一区二区三区在线观看 | 最刺激黄a大片免费观看下截 | 寂寞午夜影院 | 国产无毛| 亚洲系列| 九九九九热精品视频 | 久久精品成人国产午夜 | 中文字幕亚洲欧美 | 日本成人免费在线观看 | 欧美特级 | 全部孕妇毛片 | 在线观看日本污污ww网站 | 18video9ex欧美生活片 | 欧美一级毛片免费大全 | 中文字幕无线码中文字幕网站 | 国产麻豆交换夫妇 | 久久久99视频 | 国产美女一级视频 | 一区二区三区网站在线免费线观看 | 国产愉拍精品手机 | 欧美日韩一区二区三区四区在线观看 | 麻豆国产96在线 | 中国 | 国产精品高清一区二区 | 久久精品国产精品亚洲人人 | 亚洲第一中文字幕 | 亚洲精品中文字幕字幕 | 国产一区二区三区四区在线观看 | 久久国产精品二国产精品 | 一本色道久久综合网 | 国产老妇k | 亚洲免费视频播放 | 国产色司机在线视频免费观看 | 国产一级一国产一级毛片 | 久久精品国产精品亚洲综合 | 国产高清视频a在线大全 |